Comments
Comments to FDA: Postmarketing Safety Reports for Human Drug and Biological Products
Docket Number:
FDA-2008-N-0334
Comments regarding a proposed rule on electronic submission requirements for postmarketing safety reports for human drug and biological products.
Issues: